Welcome to LookChem.com Sign In|Join Free
  • or
2-Chloroquinoxalin-6-ol is a chlorinated quinoxaline derivative with the molecular formula C9H6ClNO, featuring a hydroxyl group attached to the sixth carbon of the quinoxaline ring. This chemical compound serves as a versatile intermediate in the synthesis of pharmaceuticals and organic chemicals, and is utilized as a research reagent in chemical and biological studies. Its potential medicinal properties are currently under investigation for the development of new drugs, although its specific biological and pharmacological activities remain to be fully elucidated.

55687-04-2

Post Buying Request

55687-04-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55687-04-2 Usage

Uses

Used in Pharmaceutical Synthesis:
2-chloroquinoxalin-6-ol is used as an intermediate in the synthesis of various pharmaceuticals and organic chemicals, contributing to the development of new compounds with potential therapeutic applications.
Used in Chemical and Biological Research:
As a research reagent, 2-chloroquinoxalin-6-ol is employed in chemical and biological studies to explore its properties, reactivity, and potential interactions with other molecules, aiding in the advancement of scientific knowledge in these fields.
Used in Drug Development:
2-chloroquinoxalin-6-ol is being investigated for its potential medicinal properties, with ongoing research aimed at understanding its biological and pharmacological activities. This may lead to its incorporation in the development of new drugs for various therapeutic applications.

Check Digit Verification of cas no

The CAS Registry Mumber 55687-04-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,6,8 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 55687-04:
(7*5)+(6*5)+(5*6)+(4*8)+(3*7)+(2*0)+(1*4)=152
152 % 10 = 2
So 55687-04-2 is a valid CAS Registry Number.

55687-04-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-6-hydroxyquinoxaline

1.2 Other means of identification

Product number -
Other names 6-hydroxy-2-chloroquinoxaline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55687-04-2 SDS

55687-04-2Relevant academic research and scientific papers

Synthesis and biological evaluation of novel technetium-99m-labeled phenylquinoxaline derivatives as single photon emission computed tomography imaging probes targeting β-amyloid plaques in Alzheimer's disease

Iikuni, Shimpei,Ono, Masahiro,Tanimura, Keiichi,Watanabe, Hiroyuki,Yoshimura, Masashi,Saji, Hideo

, p. 20582 - 20590 (2017/04/21)

The development of an imaging probe targeting β-amyloid (Aβ) plaques in Alzheimer's disease labeled with technetium-99m, the most commonly used radioisotope for clinical diagnoses, has been strongly anticipated. In this study, we synthesized three novels

Antiviral agents

-

Page/Page column 27; 28, (2016/05/02)

This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as nove

RADIOACTIVE FLUORINE-LABELED QUINOXALINE COMPOUND

-

Paragraph 0068-0069; 0144-0145, (2014/04/03)

Provided is a compound effective as a diagnostic imaging probe targeting amyloid and an agent for Alzheimer's disease diagnosis including the compound.

Structure-activity relationships and in vivo evaluation of quinoxaline derivatives for PET imaging of β-amyloid plaques

Yoshimura, Masashi,Ono, Masahiro,Matsumura, Kenji,Watanabe, Hiroyuki,Kimura, Hiroyuki,Cui, Mengchao,Nakamoto, Yuji,Togashi, Kaori,Okamoto, Yoko,Ihara, Masafumi,Takahashi, Ryosuke,Saji, Hideo

supporting information, p. 596 - 600 (2013/07/26)

This letter describes the synthesis, structure-activity relationships, and in vivo evaluation of a new series of 2-phenylquinoxaline (PQ) derivatives for imaging β-amyloid (Aβ) plaques in Alzheimer's disease (AD). In experiments in vitro, the affinity of

Antiviral agents

-

, (2008/06/13)

This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals as well as novel

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 55687-04-2